Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin

Hedgehog and Notch Signaling Regulate Self-Renewal of Undifferentiated Pleomorphic Sarcomas

(2012) C. Y. Y. Wang et al.   CANCER RESEARCH

Recombinant GPI-Anchored TIMP-1 Stimulates Growth and Migration of Peritoneal Mesothelial Cells

(2012) Roghieh Djafarzadeh et al.   PLoS One

Genotypic and Phenotypic Characterization of Side Population of Gastric Cancer Cell Lines

(2011) Rosa Schmuck et al.   AMERICAN JOURNAL OF PATHOLOGY

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways

(2011) Jens U. Marquardt et al.   HEPATOLOGY

Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition

(2009) Achim Krüger et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 γ chain-deficient mice

(2009) Matthias C. Raggi et al.   BIOLOGICAL CHEMISTRY

MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer

(2008) Anjum Sohail et al.   CANCER AND METASTASIS REVIEWS

TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis

(2008) Roghieh Djafarzadeh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY